Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7

NCT00000358 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Opioid-Related Disorders
Substance-Related Disorders

Interventions

DRUG: Lofexidine

Sponsor

National Institute on Drug Abuse (NIDA)

Collaborators

[object Object]